DekaBank Deutsche Girozentrale’s Wave Life Sciences WVE Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio WVE Stock Details WVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,000	Closed	-$237K	–	1377
2022 Q4	$237K	Buy	+35,000	New	+$161K	﹤0.01%	1196
2021 Q4	–	Sell	-27,450	Closed	-$128K	–	1489
2021 Q3	$128K	Hold	27,450	–	–	﹤0.01%	1273
2021 Q2	$177K	Hold	27,450	–	–	﹤0.01%	1247
2021 Q1	$166K	Hold	27,450	–	–	﹤0.01%	1215
2020 Q4	$211K	Hold	27,450	–	–	﹤0.01%	1177
2020 Q3	$243K	Buy	+27,450	New	+$301K	﹤0.01%	1021
2019 Q3	–	Sell	-23,000	Closed	-$604K	–	1136
2019 Q2	$604K	Buy	+23,000	New	+$645K	﹤0.01%	893

Other funds holding WVE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

DekaBank Deutsche Girozentrale's WVE Position: Q1 2023 in Review

DekaBank Deutsche Girozentrale sold out of Wave Life Sciences (WVE) in Q1 2023, closing a stake of 35,000 shares — an estimated $237K sold.

DekaBank Deutsche Girozentrale first reported a position in WVE in Q2 2019 and held it in 7 quarters. The position peaked at $604K in Q2 2019. 72 funds tracked by Wall St. Rank hold WVE as of Q1 2023.

DekaBank Deutsche Girozentrale reported no remaining Wave Life Sciences position as of Q1 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 35,000 Wave Life Sciences shares in Q1 2023, an estimated $237K.
DekaBank Deutsche Girozentrale first reported a position in Wave Life Sciences in Q2 2019 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Wave Life Sciences position peaked at $604K in Q2 2019.
72 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2023, filed 24 Apr 2023.